Revenue of €999 million (+2.8%) represents 6.1% constant currency growth;Gross profit of €321 million (+8.6%);Adjusted EBITDA margin of 13.8% is within forecast…
LONDON, April 27, 2026 /PRNewswire/ -- Concept Medical Inc., today announced the presentation of preliminary 3-year follow-up data from the…
Sanuwave is pleased to announce preliminary revenues of $9.6 million to $9.7 million for the first quarter ended March 31,…
NEW YORK, April 2, 2026—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the preliminary results of its “modified…
Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…
Oslo, Norway, 12th of February 2026 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and…
Exceeding latest 2025 guidance following a strong performance from both commercial arms of the business in Travel Health and Public…
Company Reaches Settlements in Two Separate Pending Litigation Cases to Resolve Large Portion of Potential Financial Liability February 06, 2026…
Press Release FY 2025 Preliminary and Unaudited Figures Highlighting Significant Progress in the Execution of the Genesis Plan Cash and…
January 13, 2026 07:05 ET | Source: Sight Sciences, Inc. MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight…